Dexchlorpheniramine

Table of contents

  • Brand Names
  • Drug Combinations
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Caution and personalized dose adjustment in patients with the following genotypes
  • Other genes that may be involved
  • Drug Interactions
  • Nutrition/Nutraceutical Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

Europe

Belgium: Polaramine; Denmark: Polaramin; France: Polaramine; Italy: Polaramin; Luxembourg: Polaramine; Netherlands: Polaramine; Portugal: Trenelone; Spain: Polaramine; Sweden: Polaramin.

North America

USA: Dexchlorpheniramine.

Latin America

Argentina: Afeme; Brazil: Alergonil, Dexclorfeniramina, Histamin, Hystin, Polaratin, Polaren, Polaryn.

Drug combinations

Dexchlorpheniramine and Betamethasone

Dexchlorpheniramine and Pseudoephedrine

Chemistry

Dexchlorpheniramine Maleate: C~16~H~19~ClN~2~ C~4~H~4~O~4~. Mw: 390.86. (1) 2-Pyridinepropanamine, γ-(4-chlorophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1); (2)(+)-2-[p-Chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridine maleate (1:1). CAS-2438-32-6; CAS-25523-97-1 (dexchlorpheniramine).

Pharmacologic Category

First Generation Antihistamines; Histamine H~1~ Antagonist. (ATC-Code: R06AB02).

Mechanism of action

Competes with histamine for H~1~-receptor sites on effector cells in the GI tract, blood vessels, and respiratory tract.

Therapeutic use

Perennial and seasonal allergic rhinitis and other allergic symptoms including urticaria.

Pregnancy and lactiation implications

Breast-feeding is not recommended during treatment.

Unlabeled use

Contraindications

Hypersensitivity to dexchlorpheniramine or any component of the formulation. Narrow-angle glaucoma.

Warnings and precautions

May cause CNS depression. Effects may be potentiated when used with other sedative drugs or ethanol. Caution in cardiovascular disease, increased intraocular pressure, prostatic hyperplasia and/or genitourinary obstruction, pyloroduodenal obstruction or thyroid dysfunction. May cause excitation in young children.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart